Clinical Trial Update: Valproate as First Line Therapy in Combination With Rituximab and CHOP in Diffuse Large B-cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 study from Lund University Hospital evaluated valproate in combination with Rituximab and CHOP as first-line therapy for Diffuse Lar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Valproate (valproate)
• Vincristine (vincristine)

Snippet

Sponsor: Lund University Hospital | Conditions: Diffuse Large B-cell Lymphoma | Phase 1, Phase 2 | Status: COMPLETED